Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA056125-04A2
Application #
2008019
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1991-09-30
Project End
1999-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Lydiatt, W M; Davidson, B J; Schantz, S P et al. (1998) 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck 20:113-8
Kelsen, D; Karpeh, M; Schwartz, G et al. (1996) Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14:1818-28
Davidson, B J; Lydiatt, W M; Abate, M P et al. (1996) Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck 18:512-21
Lydiatt, W M; Murty, V V; Davidson, B J et al. (1995) Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes Chromosomes Cancer 13:94-8
Murty, V V; Li, R G; Mathew, S et al. (1994) Replication error-type genetic instability at 1q42-43 in human male germ cell tumors. Cancer Res 54:3983-5
Mathew, S; Murty, V V; Bosl, G J et al. (1994) Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54:6265-9
Mitra, A B; Murty, V V; Pratap, M et al. (1994) ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res 54:637-9
Christman, K; Saltz, L; Schwartz, G et al. (1993) Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression? J Natl Cancer Inst 85:826-7
Rao, P H; Mathew, S; Lauwers, G et al. (1993) Interphase cytogenetics of gastric and esophageal adenocarcinomas. Diagn Mol Pathol 2:264-8